CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Remifentanil TCI +3 moredrug
Likely dose
Midazolam injection 2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06033729
NCT06033729N/ACompleted

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During US-guided Transbronchial Needle Aspiration (EBUS-TBNA): a Randomized, Prospective, Control Study

Scarlata, Simone, M.D.·interventional·Posted Sep 13, 2023·Updated Sep 13, 2023

In Brief

A clinical study evaluating Remifentanil TCI, Midazolam injection, and 2 other interventions for Lung Cancer and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Background: endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure for diagnosing and staging mediastinal lymph node lesions in lung cancer. Adequate sedation is crucial for patient comfort and diagnostic accuracy. Different sedation modalities, including moderate sedation/conscious sedation, deep sedation, and general anesthesia, are utilized. This study aims to evaluate patient comfort and satisfaction levels of healthcare providers (bronchoscopists and anesthesiologists) when administering remifentanil through Target Controlled Infusion (TCI) for conscious sedation during EBUS-TBNA. A prospective randomized study design compares this approach to the standard sedation protocol involving midazolam, fentanyl, and/or propofol. Methods: this study will enroll 30 eligible patients randomly divided into two groups. Group 1, "REMIFENTANIL TCI", underwent EBUS-TBNA under conscious sedation with remifentanil TCI infusion targeting a concentration of 3-6 ng/ml. Group 2, "STANDARD", received conscious sedation with a combination of midazolam, fentanyl, and/or propofol administered in boluses based on clinical requirements. Complications, safety, and satisfaction levels of the operator, anesthesiologist, and patients will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 13, 2023
Enrollment StartSep 20, 2021
Primary CompletionJul 1, 2022
Study CompletionJan 17, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 2.8 years ago

Interventions

Remifentanil TCIdrug

REMI-TCI administration begun 5 minutes before the procedure, starting from an initial target at the effect site of 1 ng/ml and gradually increasing by 0.5 ng/ml until reaching an adequate level of sedation (Ramsey score between 2-3).

Midazolam injectiondrug

Bolus administration of midazolam (1-2 mg)and/or until a Ramsey score 2-3 was reached

Fentanyldrug

Bolus adminitration of fentanyl (50-100 mcg) until a Ramsey score 2-3 was reached

Propofoldrug

Bolus adminitration of propofol until a Ramsey score 2-3 was reached